Columbia Asset Management Abbott Laboratories Transaction History

Columbia Asset Management

$493 Million
Q1 2024

A detailed history of Columbia Asset Management transactions in Abbott Laboratories stock. As of the latest transaction made, Columbia Asset Management holds 5,641 shares of ABT stock, worth $573,351. This represents 0.13% of its overall portfolio holdings.

Number of Shares

5,641

Previous 5,641 -0.0%

Holding current value

$573,351

Previous $621,000 -0.0%

% of portfolio

0.13%

Previous 0.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $124,189 - $149,006	-1,300 Reduced 18.73%	5,641 $546,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $51,335 - $60,425	530 Added 8.27%	6,941 $703,000
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $120,950 - $140,037	-1,250 Reduced 16.32%	6,411 $620,000
Q2 2022 Aug 26, 2022	BUY	$102.07 - $123.37 $12,758 - $15,421	125 Added 1.66%	7,661 $832,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $14,582 - $16,132	-125 Reduced 1.63%	7,536 $890,000

Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $818,074 - $962,990	-7,733 Reduced 50.23%	7,661 $888,000
Q1 2021 May 28, 2021	BUY	$108.84 - $128.23 $42,991 - $50,650	395 Added 2.63%	15,394 $1.85 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $1.23 Million - $1.57 Million	-15,999 Reduced 51.61%	14,999 $1.37 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $942,237 - $1.38 Million	14,999 Added 93.75%	30,998 $15.1 Million
Q4 2018 Feb 12, 2019	SELL	$65.56 - $74.27 $18,684 - $21,166	-285 Reduced 1.75%	15,999 $1.16 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $11,249 - $13,571	-185 Reduced 1.12%	16,284 $1.2 Million
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $25,321 - $28,629	450 Added 2.81%	16,469 $987,000
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $769,873 - $859,259	16,019	16,019 $855,000

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $178B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Abbott Laboratories Transaction History